Lead Compound PPL-103
A Composition of matter patent for our advanced compound, PPL-103, was filed in December, 2010 and issued in the US in March, 2015 and and has since received patent approval in major countries around the world. This patent also covers Methods of synthesis as well as Use for treatment of opioid and cocaine addiction therapy as well as pain, and Use for treatment of pain in animals.
A Use patent for the treatment of addiction using this earlier analog was issued in 2009. A Methods of synthesis patent application was filed in December, 2010 and issued in the US in 2014.